Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Infectious Disease

Where is River Blindness Most Common Geographically?

At a Glance

Over 99% of river blindness (onchocerciasis) cases occur in Sub-Saharan Africa, specifically near fast-flowing rivers. Isolated risk zones also exist in the remote Yanomami region of South America and in Yemen. Short-term travelers are at very low risk.

River blindness (medically known as onchocerciasis) is almost exclusively found in Sub-Saharan Africa, where over 99% of all global cases occur [1][2]. For travelers, missionaries, or workers, the risk is highest when spending extended periods in rural, agricultural areas near fast-flowing rivers or streams in these African nations. This environment is where the specific species of blackfly that spreads the disease breeds. Because this blackfly does not live outside these endemic zones, you cannot spread the infection to your family or coworkers back home [3][4]. While there are a few very isolated risk zones in Latin America and the Middle East, the vast majority of the risk is concentrated on the African continent [5][3].

Sub-Saharan Africa: The Primary Risk Zone

The most significant hotspots for river blindness remain in West and Central Africa [2][6].

  • High-Risk Nations: Countries with high rates of ongoing transmission include Nigeria, South Sudan, Cameroon, and the Democratic Republic of the Congo (DRC) [7][8].
  • East Africa: Countries in East Africa, like Uganda and Ethiopia, have made tremendous progress in interrupting transmission through large-scale medication distribution [9][10]. However, some remote rural pockets and cross-border regions still pose a risk [11].

In certain heavily affected African regions, the disease is so widespread that it is strongly linked to high rates of childhood epilepsy, including a condition known as nodding syndrome [12][13]. Nodding syndrome is a severe neurological disorder that causes repetitive dropping of the head. It is important to know that this complication is observed in children growing up in these specific endemic areas with prolonged exposure, and is not considered a risk for adult travelers or short-term visitors [13][12].

Latin America: One Remaining Isolated Area

In the past, river blindness was present in several Latin American countries. However, decades of aggressive public health efforts have successfully eliminated the disease in countries like Mexico and Guatemala [14][15].

Today, there is only one remaining active risk zone in the Americas, known as the Yanomami focus [5][16]. This is a remote, densely forested region straddling the border between Brazil and Venezuela [17][18]. Because of the geographic remoteness of this area, unless you are traveling deep into this specific part of the Amazon basin, your risk of catching river blindness in Latin America is practically zero [19]. Popular tourist destinations in Brazil and Venezuela, such as Rio de Janeiro or Caracas, are entirely risk-free.

Yemen: The Middle East Exception

Outside of Africa and the Americas, the only other known country where river blindness is actively transmitted is Yemen [3]. The disease remains a public health concern here, and studies have shown that many individuals may carry the infection without obvious symptoms, allowing it to persist in the region [20].

What This Means for Travelers and How to Protect Yourself

Short-term tourists visiting urban centers or typical safari destinations in these countries are generally at very low risk. Unlike malaria, which can be transmitted by a single mosquito bite, river blindness typically requires cumulative exposure to multiple infective bites over weeks or months to build up a symptomatic infection [4][21]. The disease is primarily a concern for people living in or taking extended trips to rural, river-adjacent agricultural communities.

Because there is no vaccine or preventative medication for river blindness, avoiding blackfly bites is your only defense. If you must travel to high-risk areas, keep in mind:

  • Daytime Biting: Unlike many mosquitoes that spread disease at night, the blackflies that transmit river blindness are most active and bite during the daytime [22][23].
  • Repellents: Use EPA-registered insect repellents containing DEET on all exposed skin [22].
  • Clothing: Wear long-sleeved shirts and long pants to minimize exposed skin. Treating your clothing and gear with permethrin provides an additional, highly effective layer of protection [23].

Common questions in this guide

Where is river blindness most common?
River blindness is almost exclusively found in Sub-Saharan Africa, which accounts for over 99% of global cases. It is most prevalent in West and Central African countries, including Nigeria, South Sudan, Cameroon, and the Democratic Republic of the Congo.
Can I catch river blindness in Latin America?
The risk in Latin America is practically zero for most travelers. While it used to be more widespread, the only remaining active risk zone is the Yanomami focus, a remote, densely forested region on the border of Brazil and Venezuela.
Are short-term tourists at risk for river blindness?
Short-term tourists visiting urban centers or typical safari destinations are at very low risk. The disease usually requires cumulative exposure to multiple blackfly bites over weeks or months to build up a symptomatic infection.
How can I protect myself from river blindness when traveling?
Since there is no vaccine or preventative medication, your only defense is avoiding blackfly bites. Wear long sleeves and pants treated with permethrin, and apply an EPA-registered DEET repellent to exposed skin during the daytime when blackflies are most active.
Should I be screened for river blindness after traveling to a high-risk area?
If you spent an extended period living or working near fast-flowing rivers in an endemic area and sustained multiple daytime insect bites, you should consult a doctor. They can determine if screening is appropriate even if you have not developed symptoms yet.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I am planning extended travel to a high-risk area in Sub-Saharan Africa, what specific insect repellents or clothing treatments do you recommend for blackflies?
  2. 2.Since I recently returned from a long-term stay near a river in a high-risk country, should I be screened for river blindness even if I don't have symptoms yet?
  3. 3.If I sustained multiple daytime insect bites during my trip to an endemic area, how long should I wait before seeking an evaluation to ensure an accurate diagnosis?
  4. 4.Is my past travel to a country that has recently eliminated river blindness still a cause for concern regarding my current eye or skin symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?.

    El-Bahnasawy MM, Morsy AT, Morsy TA

    Journal of the Egyptian Society of Parasitology 2015; (45(3)):639-54 doi:10.12816/0017932.

    PMID: 26939243
  2. 2

    The prevalence of onchocerciasis in Africa and Yemen, 2000-2018: a geospatial analysis.

    Schmidt CA, Cromwell EA, Hill E, et al.

    BMC medicine 2022; (20(1)):293 doi:10.1186/s12916-022-02486-y.

    PMID: 36068517
  3. 3

    Onchocerciasis in Yemen: Time to take action against a neglected tropical parasitic disease.

    Abdul-Ghani R, Mahdy MAK, Beier JC

    Acta tropica 2016; (162()):133-141 doi:10.1016/j.actatropica.2016.06.017.

    PMID: 27325293
  4. 4

    Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.

    Hendy A, Krit M, Pfarr K, et al.

    Parasites & vectors 2021; (14(1)):563 doi:10.1186/s13071-021-05072-y.

    PMID: 34727965
  5. 5

    River Epilepsy-A Preventable Form of Epilepsy.

    Widdess-Walsh P

    Epilepsy currents 2024; (24(3)):174-176 doi:10.1177/15357597241235785.

    PMID: 38898913
  6. 6

    Prevalence of onchocerciasis and epilepsy in a Tanzanian region after a prolonged community-directed treatment with ivermectin.

    Mushi VP, Bhwana D, Massawe IS, et al.

    PLoS neglected tropical diseases 2024; (18(9)):e0012470 doi:10.1371/journal.pntd.0012470.

    PMID: 39241094
  7. 7

    Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis-A Report of Post-Ivermectin Mass Drug Administration Surveillance.

    Miri ES, Eigege A, Kahansim B, et al.

    The American journal of tropical medicine and hygiene 2023; (108(1)):37-40 doi:10.4269/ajtmh.22-0491.

    PMID: 36450227
  8. 8

    Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control.

    Siewe Fodjo JN, Remme JHF, Preux PM, Colebunders R

    International health 2020; (12(3)):192-202 doi:10.1093/inthealth/ihaa012.

    PMID: 32141502
  9. 9

    The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.

    Luroni LT, Gabriel M, Tukahebwa E, et al.

    PloS one 2017; (12(12)):e0189306 doi:10.1371/journal.pone.0189306.

    PMID: 29253862
  10. 10

    River blindness in East Africa: gains and losses.

    Nakkazi E

    BMJ (Clinical research ed.) 2020; (368()):m155 doi:10.1136/bmj.m155.

    PMID: 31964681
  11. 11

    The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.

    Katabarwa MN, Zarroug IMA, Negussu N, et al.

    PLoS neglected tropical diseases 2020; (14(2)):e0007830 doi:10.1371/journal.pntd.0007830.

    PMID: 32027648
  12. 12

    The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey.

    Jada SR, Dusabimana A, Abd-Elfarag G, et al.

    Pathogens (Basel, Switzerland) 2022; (11(4)) doi:10.3390/pathogens11040396.

    PMID: 35456071
  13. 13

    The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan.

    Sube KL, Lako JDW, Tongun JB, et al.

    Research and reports in tropical medicine 2024; (15()):111-121 doi:10.2147/RRTM.S481554.

    PMID: 39735383
  14. 14

    Elimination of Onchocerciasis from Mexico.

    Rodríguez-Pérez MA, Fernández-Santos NA, Orozco-Algarra ME, et al.

    PLoS neglected tropical diseases 2015; (9(7)):e0003922 doi:10.1371/journal.pntd.0003922.

    PMID: 26161558
  15. 15

    One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.

    Richards F, Rizzo N, Diaz Espinoza CE, et al.

    The American journal of tropical medicine and hygiene 2015; (93(6)):1295-304 doi:10.4269/ajtmh.15-0364.

    PMID: 26503275
  16. 16

    Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.

    Botto C, Basañez MG, Escalona M, et al.

    Parasites & vectors 2016; (9()):40 doi:10.1186/s13071-016-1313-z.

    PMID: 26813296
  17. 17

    Onchocerciasis Elimination: Progress and Challenges.

    Lakwo T, Oguttu D, Ukety T, et al.

    Research and reports in tropical medicine 2020; (11()):81-95 doi:10.2147/RRTM.S224364.

    PMID: 33117052
  18. 18

    Progress Toward Onchocerciasis Elimination in Brazil.

    Pereira de Araujo JL, Ríos D, Grillet ME, et al.

    The American journal of tropical medicine and hygiene 2024; (111(3_Suppl)):137-140 doi:10.4269/ajtmh.23-0749.

    PMID: 38981465
  19. 19

    Challenges in the implementation of mass drug administration programs with ivermectin for the control and elimination of onchocerciasis: a scoping review protocol.

    Geomor K, Bogensberger K, van der Zee-Neuen A

    JBI evidence synthesis 2025; doi:10.11124/JBIES-24-00543.

    PMID: 41215598
  20. 20

    A Serological Survey of Human Onchocerciasis in Yemen.

    Mackenzie CD, Al-Kubati AS, Al-Qubati Y, et al.

    The American journal of tropical medicine and hygiene 2018; (99(4)):1049-1052 doi:10.4269/ajtmh.18-0051.

    PMID: 30084341
  21. 21

    Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.

    Releve epidemiologique hebdomadaire 2017; (92(41)):617-23.

    PMID: 29028167
  22. 22

    Risk of Attacks by Blackflies (Diptera: Simuliidae) and Occurrence of Severe Skin Symptoms in Bitten Patients along the Eastern Border of the European Union.

    Sitarz M, Buczek AM, Buczek W, et al.

    International journal of environmental research and public health 2022; (19(13)) doi:10.3390/ijerph19137610.

    PMID: 35805269
  23. 23

    Biting rates and relative abundance of Simulium flies under different climatic conditions in an onchocerciasis endemic community in Ghana.

    Otabil KB, Gyasi SF, Awuah E, et al.

    Parasites & vectors 2020; (13(1)):229 doi:10.1186/s13071-020-04102-5.

    PMID: 32375902

This page provides geographic risk information for educational purposes and does not replace professional medical advice. Always consult a travel medicine specialist before visiting high-risk areas to discuss personalized prevention strategies.

Get notified when new evidence is published on Onchocerciasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.